Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents

被引：0
|
作者：
Terence O’Reilly
Paul M. J. McSheehy
R. Kawai
O. Kretz
L. McMahon
J. Brueggen
A. Bruelisauer
H.-P. Gschwind
P. R. Allegrini
H. A. Lane
机构：
[1] Novartis Institutes for BioMedical Research,Department of Oncology Research
[2] Novartis Pharma AG,Department of Drug Metabolism and Pharmacokinetics
[3] Novartis Institutes for BioMedical Research,Department of Drug Metabolism and Pharmacokinetics
[4] Novartis Institutes for BioMedical Research,Department of Oncology Research
[5] Basilea Pharmaceutica International AG,undefined
[6] Wyeth Medica Ireland,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 65卷
关键词：
Everolimus; RAD001; Pharmacokinetics; Mice; Rat; Tumor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：625 / 639
页数：14
相关论文
共 50 条
  • [1] Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents
    O'Reilly, Terence
    McSheehy, Paul M. J.
    Kawai, R.
    Kretz, O.
    McMahon, L.
    Brueggen, J.
    Bruelisauer, A.
    Gschwind, H. -P.
    Allegrini, P. R.
    Lane, H. A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (04) : 625 - 639
  • [2] Pharmacokinetics of RAD001, an orally active rapamycin derivative, in tumor-bearing mice and rats.
    Boulay, A
    O'Reilly, T
    McMahon, L
    Brüggen, J
    Stolz, B
    Haller, R
    Muller, M
    Tobler, S
    Vaxelaire, J
    Hattenberger, M
    Lane, HA
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6257S - 6257S
  • [3] RAD001 (everolimus)
    Soria, J. C.
    ANNALS OF ONCOLOGY, 2008, 19 : 21 - 22
  • [4] Everolimus (RAD001) compassionate supplies programme
    Chambers, J. S.
    REGULATORY PEPTIDES, 2010, 164 (01) : 10 - 10
  • [5] Adrenocortical Cancer: A Therapeutic Approach with Everolimus (RAD001)
    Gueorguiev, M.
    Bhattacharya, S.
    Grossman, A.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 33 - 33
  • [6] Everolimus (RAD001) and solid tumours : a 2008 summary
    Levy, A.
    Sauvin, L. Albiges
    Massard, C.
    Soria, J. -C.
    BULLETIN DU CANCER, 2008, 95 (12) : 1205 - 1211
  • [7] PHARMACOKINETICS OF MISONIDAZOLE IN NORMAL AND TUMOR-BEARING DOGS
    WHITE, RAS
    WORKMAN, P
    OWEN, LN
    BLEEHEN, NM
    BRITISH JOURNAL OF CANCER, 1978, 38 (01) : 194 - 194
  • [8] PHARMACOKINETIC ANALYSIS OF NEOCARZINOSTATIN IN NORMAL AND TUMOR-BEARING RODENTS
    LOWENTHAL, IS
    PARKER, LM
    GREENBLATT, DJ
    BROWN, BL
    SAMY, TSA
    CANCER RESEARCH, 1979, 39 (05) : 1547 - 1551
  • [9] RAD001 (everolimus) induces autophagy in acute lymphoblastic leukemia
    Crazzolara, Roman
    Bradstock, Kenneth F.
    Bendall, Linda J.
    AUTOPHAGY, 2009, 5 (05) : 727 - 728
  • [10] RAD001 (everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer
    Mabuchi, Seiji
    Altomare, Deborah A.
    Connolly, Denise C.
    Klein-Szanto, Andres
    Litwin, Samuel
    Hoelzle, Matthew K.
    Hensley, Harvey H.
    Hamilton, Thomas C.
    Testa, Joseph R.
    CANCER RESEARCH, 2007, 67 (06) : 2408 - 2413
12345